Aimmune Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results by Carolyn Helms | Mar 15, 2017 | Portfolio News
Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update by Carolyn Helms | Mar 9, 2017 | Portfolio News
Aimmune Therapeutics Presents Clinical Data on Phase 3 Screening and Phase 2 Adherence for AR101 for Peanut Allergy at the 2017 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting by Carolyn Helms | Mar 6, 2017 | Portfolio News
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results; Increases 2017 Revenue Guidance by Carolyn Helms | Mar 6, 2017 | Portfolio News
Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2016 Financial Results by Carolyn Helms | Feb 28, 2017 | Portfolio News
